Trade Cardinal Health - CAH CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.39
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022207 %(-$4.44)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.02221%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000015 %(-$0.00)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.00002%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022207 %
  (-$4.44)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000015 %
  (-$0.00)

Key Stats

• Prev. Close: 222.34
• Open: 221.43
• 1-Year Change: 43.37%
• Day's Range: 218.62 - 221.43

Trade Cardinal Health - CAH

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Financial summary

BRIEF: For the six months ended 31 December 2021, Cardinal Health Inc revenues increased 11% to $89.43B. Net income decreased 15% to $320M. Revenues reflect Pharmaceutical segment increase of 12% to $81.2B, United States segment increase of 11% to $87.22B. Net income was offset by Medical segment income decrease of 63% to $173M, Corporate segment loss increase of 7% to $1.54B. Dividend per share increased from $0.97 to $1.47.

Equity composition

Common no Par, 3/11, 755M auth., 363,600,000 issd., less 13,300,000 in Treas. @ $487.2M. Insiders & Strategic holders own 0.10%. IPO:9/94, 7M shs @ $39 by Smith Barney. *FY'97 -'99 fncls & '98-'99 Q rest'd for merger with Scherer(8/98),llegiance (3/99), PSI(5/99), & ALP (9/99).